| scholarly article | Q13442814 |
| P50 | author | Shea Ping Yip | Q40246343 |
| Benjamin Yat Ming Yung | Q67542393 | ||
| P2093 | author name string | S Y Lee | |
| S K Luk | |||
| S S T To | |||
| C P Chuang | |||
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage | Q28364113 | ||
| The role of the p53 tumor suppressor in the response of human cells to photofrin-mediated photodynamic therapy | Q28371017 | ||
| Repair of methylation damage in DNA and RNA by mammalian AlkB homologues | Q28506420 | ||
| Mechanisms of human DNA repair: an update | Q28608973 | ||
| The comet assay: what can it really tell us? | Q29038672 | ||
| Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function | Q29617871 | ||
| Role of p53 and ATM in photodynamic therapy-induced apoptosis | Q30733185 | ||
| Direct tumor damage mechanisms of photodynamic therapy. | Q30787032 | ||
| Photodynamic therapy for head and neck dysplasia and cancer | Q30872316 | ||
| The effect of photofrin on DNA strand breaks and base oxidation in HaCaT keratinocytes: a comet assay study | Q31048907 | ||
| Photodynamic therapy with photofrin in combination with Buthionine Sulfoximine (BSO) of human glioma in the nude rat | Q33193218 | ||
| Advances in photodynamic therapy for the treatment of head and neck cancers | Q33247403 | ||
| Sensitization of cerebral tissue in nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion | Q33325051 | ||
| Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage. | Q33371561 | ||
| Reactive oxygen-dependent production of novel photochemotherapeutic agents | Q34190140 | ||
| Reversal of DNA alkylation damage by two human dioxygenases | Q34429515 | ||
| Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm | Q34632917 | ||
| AlkB homologue 2-mediated repair of ethenoadenine lesions in mammalian DNA. | Q36498994 | ||
| Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer? | Q37485152 | ||
| DNA repair and resistance of gliomas to chemotherapy and radiotherapy | Q37553777 | ||
| Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy | Q37580050 | ||
| Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT. | Q37662018 | ||
| Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer | Q39846028 | ||
| Photooxidative action in cancer and normal cells induced by the use of photofrin in photodynamic therapy. | Q40019785 | ||
| Cytosolic superoxide dismutase activity after photodynamic therapy, intracellular distribution of Photofrin II and hypericin, and P-glycoprotein localization in human colon adenocarcinoma. | Q40114349 | ||
| Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response | Q40131228 | ||
| Intracellular distribution of Photofrin in malignant and normal endothelial cell lines. | Q40165449 | ||
| Differential effects of photofrin, 5-aminolevulinic acid and calphostin C on glioma cells. | Q40257254 | ||
| Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro | Q40420654 | ||
| Mutagenicity of photodynamic therapy as compared to UVC and ionizing radiation in human and murine lymphoblast cell lines | Q41072543 | ||
| The role of DNA damage and inhibition of poly(ADP-ribosyl)ation in loss of clonogenicity of murine L929 fibroblasts, caused by photodynamically induced oxidative stress. | Q41432060 | ||
| Photodynamic action and chromosomal damage: a comparison of haematoporphyrin derivative (HpD) and light with X-irradiation | Q41495097 | ||
| The role of p53 in the efficiency of photodynamic therapy with hypericin and subsequent long-term survival of colon cancer cells. | Q43253736 | ||
| Cellular uptake, localization and photodynamic effects of haematoporphyrin derivative in human glioma and squamous carcinoma cell lines | Q44360068 | ||
| Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome | Q44984347 | ||
| Pediatric brain tumors: mutations of two dioxygenases (hABH2 and hABH3) that directly repair alkylation damage | Q48703360 | ||
| Evaluation of an automated instrument for viability and concentration measurements of cryopreserved hematopoietic cells. | Q50489286 | ||
| m-THPC-mediated photodynamic therapy (PDT) does not induce resistance to chemotherapy, radiotherapy or PDT on human breast cancer cells in vitro. | Q54119127 | ||
| In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy | Q60339190 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 362-369 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy | |
| P478 | volume | 103 |
| Q90100843 | ALKBH overexpression in head and neck cancer: potential target for novel anticancer therapy |
| Q41377115 | Acetylation of hMOF Modulates H4K16ac to Regulate DNA Repair Genes in Response to Oxidative Stress. |
| Q35103629 | Apoptosis-associated genes related to photodynamic therapy in breast carcinomas. |
| Q33955386 | Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy |
| Q37676323 | Interaction and oxidative damage of DVDMS to BSA: a study on the mechanism of photodynamic therapy-induced cell death |
| Q37727692 | Nucleic acid oxidation in DNA damage repair and epigenetics |
| Q38240032 | Oncometabolites-driven tumorigenesis: From genetics to targeted therapy |
| Q38793244 | Progression inference for somatic mutations in cancer |
| Q43242899 | The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells |
| Q89551765 | Using Light for Therapy of Glioblastoma Multiforme (GBM) |
Search more.